Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A study characterized the gut microbiota of patients with Clostridioides difficile infection (CDI) and found that a reduced abundance of Bacteroidaceae was associated with a poor CDI prognosis, severe diarrhea, and a high incidence of recurrence. This reduction was linked to a weakened host immune system and previous aggressive antibiotic therapy
The abundance of Bacteroidaceae in the gut microbiota may play a significant role in the development and prognosis of CDI.
see also:
Clostridioides difficile infection (CDI) & Dysbiosis
…